Results 61 to 70 of about 7,595,633 (393)

Consenso mexicano de cáncer mamario. Manejo del cáncer de mama en poblaciones especiales

Gaceta Mexicana de Oncolog�a
El cáncer mamario en poblaciones especiales (mujeres jóvenes, de edad avanzada, en embarazo o lactancia, hombres) requiere de consideraciones especiales de manejo sistémico, quirúrgico y radioterapia. La décima actualización del Consenso Mexicano Sobre Diagnóstico y Tratamiento del Cáncer Mamario (Colima, enero de 2023) es publicada por sus autores en ...
Laura Torrecillas-Torres, Claudia Arce-Salinas, Juan E. Bargalló-Rocha, Verónica Bautista-Piña, Guadalupe Cervantes-Sánchez, Mariana Chávez-MacGregor, Christian H. Flores-Balcázar, Ma. del Carmen Lara-Tamburrino, Ana Lluch-Hernández, Antonio Maffuz-Aziz, Víctor M. Pérez-Sánchez, Adela Poitevin-Chacón, Efraín Salas-González, Enrique Soto-Pérez-de-Celis, Vicente Valero-Castillo, Yolanda Villaseñor-Navarro, Jesús Cárdenas-Sánchez   +16 more
openaire   +2 more sources

Biomarcadores y características del tratamiento en pacientes con cáncer colorrectal metastásico RAS en América Latina

Gaceta Mexicana de Oncología, 2023
Objetivo: Describir del uso de biomarcadores y los tratamientos utilizados en pacientes RAS-silvestre con cáncer colorrectal metastásico (CCRm) en 3 países de Latinoamérica durante el periodo 2017-2019. Métodos: Se realizó un análisis descriptivo de fuentes de datos estructuradas privadas para conocer el acceso a tratamientos y el uso de biomarcadores,
Juan O’Connor, Laura Torrecillas-Torres, Francisco Alvarado, Cecilia Colombero, Andre Sasse   +4 more
openaire   +1 more source

Tendencias de mortalidad y riesgo de muerte por cáncer de hígado en México, 2000-2013 [PDF]

Cirugía y Cirujanos, 2021
Liver cancer (LC) is a public health problem in the world, since is the second leading cause of death and Mexico is no exception, in 2013 the LC ranked fourth of mortality among malignancies.The records of mortality associated to LC for the period 2000-2013 were obtained from National Institute of Statistics and Geography. National mortality rates were
openaire   +4 more sources

End-of-life care needs in cancer patients: a qualitative study of patient and family experiences

BMC Palliative Care
Background Cancer is a disease that transcends what is purely medical, profoundly affecting the day-to-day life of both patients and family members. Previous research has shown that the consequences of cancer are greatly aggravated in patients at the end
Mario López-Salas, Antonio Yanes-Roldán, Ana Fernández, Ainhoa Marín, Ana I. Martínez, Ana Monroy, José M. Navarro, Marta Pino, Raquel Gómez, Saray Rodríguez, Sergio Garrido, Sonia Cousillas, Tatiana Navas, Víctor Lapeña, Belén Fernández   +14 more
doaj   +1 more source

Population and breast cancer patients’ analysis reveals the diversity of genomic variation of the BRCA genes in the Mexican population

Human Genomics, 2019
Interpretation of variants of unknown significance (VUS) in genetic tests is complicated in ethnically diverse populations, given the lack of information regarding the common spectrum of genetic variation in clinically relevant genes. Public availability
J. C. Fernández-Lopez, S. Romero-Córdoba, R. Rebollar-Vega, L. A. Alfaro-Ruiz, S. Jiménez-Morales, F. Beltrán-Anaya, R. Arellano-Llamas, A. Cedro-Tanda, M. Rios-Romero, M. Ramirez-Florencio, V. Bautista-Piña, C. Dominguez-Reyes, F. Villegas-Carlos, A. Tenorio-Torres, A. Hidalgo-Miranda   +14 more
doaj   +1 more source

Cáncer y depresión en adultos mayores

Gaceta Mexicana de Oncolog�a
Antecedentes: Las enfermedades oncológicas conllevan la expresión de múltiples reacciones adversas, que pueden ser físicas o mentales. Objetivo: Determinar la asociación entre reacciones adversas en personas mayores en tratamiento oncológico y depresión. Método: Diseño observacional, de tipo cohorte retrospectiva.
Raúl Villanueva-Salazar, Adriana Díaz-Baquerizo, Ana L. Tintaya-Pelaes, Cielo A. Estela-Fernández, José F. Parodi, Fernando Runzer-Colmenares   +5 more
openaire   +2 more sources

Insights into PI3K/AKT signaling in B cell development and chronic lymphocytic leukemia

FEBS Letters, EarlyView.
This Review explores how the phosphoinositide 3‐kinase and protein kinase B pathway shapes B cell development and drives chronic lymphocytic leukemia, a common blood cancer. It examines how signaling levels affect disease progression, addresses treatment challenges, and introduces novel experimental strategies to improve therapies and patient outcomes.
Maike Buchner
wiley   +1 more source

Cancer treatment and survivorship statistics, 2016

Ca, 2016
The number of cancer survivors continues to increase because of both advances in early detection and treatment and the aging and growth of the population.
K. D. Miller, R. Siegel, C. Lin, A. Mariotto, J. Kramer, J. Rowland, K. Stein, Rick Alteri, A. Jemal   +8 more
semanticscholar   +1 more source

Breast Cancer Statistics, 2022

Ca, 2022
This article is the American Cancer Society’s update on female breast cancer statistics in the United States, including population‐based data on incidence, mortality, survival, and mammography screening.
Angela N Giaquinto, H. Sung, K. D. Miller, J. Kramer, L. Newman, Adair K. Minihan, A. Jemal, R. Siegel   +7 more
semanticscholar   +1 more source

The cytoskeletal control of B cell receptor and integrin signaling in normal B cells and chronic lymphocytic leukemia

FEBS Letters, EarlyView.
In lymphoid organs, antigen recognition and B cell receptor signaling rely on integrins and the cytoskeleton. Integrins act as mechanoreceptors, couple B cell receptor activation to cytoskeletal remodeling, and support immune synapse formation as well as antigen extraction.
Abhishek Pethe, Tanja Nicole Hartmann
wiley   +1 more source